John Hastewell
Directeur/Membre du Conseil chez Marengo Therapeutics, Inc.
Profil
John Hastewell is an Independent Director at Marengo Therapeutics, Inc. since 2018.
He completed his undergraduate degree from the University of Oxford in 1904.
Postes actifs de John Hastewell
| Sociétés | Poste | Début |
|---|---|---|
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/08/2018 |
Formation de John Hastewell
| University of Oxford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Health Technology |